Payment overview · 2025
General Payments
$107.81
3 reported records · 2 companies
Healthcare provider profile · identity verified
David Clayton Smith, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · LEHI, UT · NPI 1154575637
Verified facts
What the public records show
CMS Open Payments records show David Clayton Smith, M.D. received $107.81 in general payments during 2025 across 3 reported records.
BIOTRONIK NRO, Inc. accounted for 86.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| BIOTRONIK NRO, Inc. | Unresolved — no canonical attribution shown | $92.96 | 86.2% | 2 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $14.85 | 13.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $107.81 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Prospera Normalized: prospera |
Device | BIOTRONIK NRO, Inc. | $92.96 | 2 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $14.85 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 727 | 94 |
| Atorvastatin Calcium | Atorvastatin Calcium | 520 | 106 |
| Levothyroxine Sodium | Levothyroxine Sodium | 489 | 88 |
| Furosemide | Furosemide | 435 | 85 |
| Potassium Chloride | Potassium Chloride | 396 | 96 |
| Gabapentin | Gabapentin | 357 | 81 |
| Trazodone Hcl | Trazodone Hcl | 301 | 57 |
| Sertraline Hcl | Sertraline Hcl | 287 | 42 |
| Duloxetine Hcl | Duloxetine Hcl | 236 | 41 |
| Losartan Potassium | Losartan Potassium | 215 | 47 |
| Amlodipine Besylate | Amlodipine Besylate | 200 | 48 |
| Pantoprazole Sodium | Pantoprazole Sodium | 190 | 49 |
| Metformin Hcl | Metformin Hcl | 182 | 41 |
| Tamsulosin Hcl | Tamsulosin Hcl | 170 | 39 |
| Levetiracetam | Levetiracetam | 166 | 26 |
| Allopurinol | Allopurinol | 161 | 19 |
| Jardiance | Empagliflozin | 161 | 15 |
| Lisinopril | Lisinopril | 161 | 44 |
| Omeprazole | Omeprazole | 158 | 48 |
| Escitalopram Oxalate | Escitalopram Oxalate | 144 | 28 |
| Baclofen | Baclofen | 141 | 21 |
| Famotidine | Famotidine | 133 | 29 |
| Buspirone Hcl | Buspirone Hcl | 130 | 16 |
| Metoprolol Tartrate | Metoprolol Tartrate | 129 | 36 |
| Ondansetron Hcl | Ondansetron Hcl | 119 | 56 |
| Carvedilol | Carvedilol | 117 | 29 |
| Clopidogrel | Clopidogrel Bisulfate | 115 | 25 |
| Metoprolol Succinate | Metoprolol Succinate | 111 | 27 |
| Lactulose | Lactulose | 106 | 28 |
| Divalproex Sodium | Divalproex Sodium | 104 | 21 |
| Liothyronine Sodium | Liothyronine Sodium | 100 | suppressed |
| Memantine Hcl | Memantine Hcl | 99 | 13 |
| Myrbetriq | Mirabegron | 96 | 14 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 94 | suppressed |
| Mirtazapine | Mirtazapine | 92 | 26 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 92 | 35 |
| Tradjenta | Linagliptin | 90 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 88 | 27 |
| Oxycodone Hcl | Oxycodone Hcl | 86 | 46 |
| Methenamine Hippurate | Methenamine Hippurate | 84 | suppressed |
| Xarelto | Rivaroxaban | 84 | 11 |
| Alendronate Sodium | Alendronate Sodium | 83 | 17 |
| Donepezil Hcl | Donepezil Hcl | 83 | 14 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 81 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 76 | 43 |
| Quetiapine Fumarate | Quetiapine Fumarate | 75 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 72 | 39 |
| Hydrochlorothiazide | Hydrochlorothiazide | 72 | 22 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 72 | 17 |
| Spironolactone | Spironolactone | 72 | 20 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 72 | suppressed |
| Celecoxib | Celecoxib | 71 | 15 |
| Tramadol Hcl | Tramadol Hcl | 71 | 39 |
| Olanzapine | Olanzapine | 69 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 67 | suppressed |
| Nystatin | Nystatin | 66 | 29 |
| Simvastatin | Simvastatin | 66 | 18 |
| Ropinirole Hcl | Ropinirole Hcl | 64 | 14 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 63 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 63 | 19 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 63 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 62 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 62 | suppressed |
| Bupropion Xl | Bupropion Hcl | 61 | 18 |
| Midodrine Hcl | Midodrine Hcl | 57 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 57 | 11 |
| Farxiga | Dapagliflozin Propanediol | 55 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 55 | 16 |
| Finasteride | Finasteride | 54 | 12 |
| Glimepiride | Glimepiride | 54 | 11 |
| Sucralfate | Sucralfate | 54 | 14 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 53 | 18 |
| Torsemide | Torsemide | 53 | suppressed |
| Glipizide | Glipizide | 52 | suppressed |
| Trulicity | Dulaglutide | 52 | suppressed |
| Aripiprazole | Aripiprazole | 51 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 51 | suppressed |
| Clonazepam | Clonazepam | 50 | 16 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 49 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 49 | suppressed |
| Meloxicam | Meloxicam | 48 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 46 | 27 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 45 | 20 |
| Primidone | Primidone | 45 | suppressed |
| Januvia | Sitagliptin Phosphate | 44 | suppressed |
| Ondansetron Odt | Ondansetron | 44 | 21 |
| Pregabalin | Pregabalin | 43 | 18 |
| Doxazosin Mesylate | Doxazosin Mesylate | 42 | suppressed |
| Bumetanide | Bumetanide | 41 | suppressed |
| Cephalexin | Cephalexin | 41 | 27 |
| Humalog Kwikpen U-100 | Insulin Lispro | 41 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 41 | 14 |
| Lorazepam | Lorazepam | 41 | 15 |
| Metformin Hcl Er | Metformin Hcl | 41 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 40 | 26 |
| Fluoxetine Hcl | Fluoxetine Hcl | 39 | 13 |
| Amiodarone Hcl | Amiodarone Hcl | 38 | 18 |
| Calcitriol | Calcitriol | 37 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 37 | suppressed |
| Carbamazepine | Carbamazepine | 36 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 32 | 25 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 32 | 17 |
| Propranolol Hcl Er | Propranolol Hcl | 32 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 31 | 12 |
| Latanoprost | Latanoprost | 31 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 29 | suppressed |
| Budesonide | Budesonide | 28 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 28 | suppressed |
| Valsartan | Valsartan | 28 | suppressed |
| Fluconazole | Fluconazole | 27 | 19 |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 27 | suppressed |
| Methocarbamol | Methocarbamol | 26 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 26 | 19 |
| Propranolol Hcl | Propranolol Hcl | 26 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 25 | suppressed |
| Prednisone | Prednisone | 25 | 19 |
| Warfarin Sodium | Warfarin Sodium | 25 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 24 | 16 |
| Amoxicillin | Amoxicillin | 23 | 19 |
| Bupropion Hcl | Bupropion Hcl | 23 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 23 | suppressed |
| Topiramate | Topiramate | 23 | suppressed |
| Acetazolamide | Acetazolamide | 22 | suppressed |
| Azithromycin | Azithromycin | 22 | 15 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 22 | 17 |
| Ertapenem | Ertapenem Sodium | 22 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 21 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 21 | suppressed |
| Irbesartan | Irbesartan | 21 | suppressed |
| Ozempic | Semaglutide | 21 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 21 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 20 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 20 | suppressed |
| Hydrocortisone | Hydrocortisone | 20 | suppressed |
| Progesterone | Progesterone, Micronized | 20 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 20 | suppressed |
| Chlorthalidone | Chlorthalidone | 19 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 19 | 12 |
| Mupirocin | Mupirocin | 19 | suppressed |
| Nystop | Nystatin | 19 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | suppressed |
| Lamotrigine | Lamotrigine | 18 | suppressed |
| Meropenem | Meropenem | 18 | suppressed |
| Atenolol | Atenolol | 17 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Lacosamide | Lacosamide | 17 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 17 | 15 |
| Nyamyc | Nystatin | 17 | suppressed |
| Risperidone | Risperidone | 17 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 17 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 17 | 11 |
| Cefuroxime | Cefuroxime Axetil | 16 | 13 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 16 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 16 | suppressed |
| Riluzole | Riluzole | 16 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 16 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 16 | suppressed |
| Levofloxacin | Levofloxacin | 15 | 14 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 15 | suppressed |
| Mirabegron Er | Mirabegron | 15 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 14 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Fentanyl | Fentanyl | 14 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 14 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 14 | suppressed |
| Estradiol | Estradiol | 13 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Humalog | Insulin Lispro | 13 | suppressed |
| Lamotrigine Er | Lamotrigine | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 13 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 13 | suppressed |
| Rexulti | Brexpiprazole | 13 | suppressed |
| Scopolamine | Scopolamine | 13 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 13 | suppressed |
| Gemtesa | Vibegron | 12 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 12 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 12 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 12 | suppressed |
| Metronidazole | Metronidazole | 12 | suppressed |
| Mounjaro | Tirzepatide | 12 | suppressed |
| Movantik | Naloxegol Oxalate | 12 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 12 | suppressed |
| Xeljanz Xr | Tofacitinib Citrate | 12 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 11 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 11 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | suppressed |
| Lansoprazole | Lansoprazole | 11 | suppressed |
| Metolazone | Metolazone | 11 | suppressed |
| Norethindrone Acetate | Norethindrone Acetate | 11 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $107.81 · 3 records | BIOTRONIK NRO, Inc. | INGREZZA, Prospera | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error